A select number of drug companies are moving towards transparency by divulging their payments to doctors. The voluntary program aims to address the public perception between drug companies and doctors. But critics saying they aren't moving far enough or fast enough.
from CBC | Health News http://ift.tt/235TP0q
Aucun commentaire:
Enregistrer un commentaire